open access

Online first
Short communication
Published online: 2021-06-27
Get Citation

Evolution of implantation technique and indications for a subcutaneous cardioverter-defibrillator over 7 years of experience in Poland

Maciej Kempa, Andrzej Przybylski, Szymon Budrejko, Wojciech Krupa, Krzysztof Kaczmarek, Mateusz Ostręga, Paweł Syska, Adam Sokal, Marcin Grabowski, Dariusz Jagielski, Maciej Grymuza, Janusz Romanek, Stanisław Tubek, Marcin Janowski, Zbigniew Orski, Joanna Zakrzewska-Koperska, Adrian Stanek, Michał Orszulak
DOI: 10.33963/KP.a2021.0048
·
Pubmed: 34176114

open access

Online first
Short communication
Published online: 2021-06-27

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Evolution of implantation technique and indications for a subcutaneous cardioverter-defibrillator over 7 years of experience in Poland

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Short communication

Published online

2021-06-27

DOI

10.33963/KP.a2021.0048

Pubmed

34176114

Authors

Maciej Kempa
Andrzej Przybylski
Szymon Budrejko
Wojciech Krupa
Krzysztof Kaczmarek
Mateusz Ostręga
Paweł Syska
Adam Sokal
Marcin Grabowski
Dariusz Jagielski
Maciej Grymuza
Janusz Romanek
Stanisław Tubek
Marcin Janowski
Zbigniew Orski
Joanna Zakrzewska-Koperska
Adrian Stanek
Michał Orszulak

References (13)
  1. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015; 36(41): 2793–2867.
  2. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society. Heart Rhythm. 2018; 15(10): e190–e252.
  3. Kaczmarek K, Kempa M, Grabowski M, et al. A subcutaneous implantable cardioverter-defibrillator - the first implantation in Poland. Kardiol Pol. 2015; 73(1): 62–771.
  4. Kempa M, Budrejko S, Sławiński G, et al. Subcutaneous implantable cardioverter-defibrillator (S-ICD) for secondary prevention of sudden cardiac death. Arch Med Sci. 2016; 12(5): 1179–1180.
  5. Rozporządzenie Ministra Zdrowia z dnia 9 stycznia 2019 r. zmieniające rozporządzenie w sprawie świadczeń gwarantowanych z zakresu leczenia szpitalnego. Dziennik Ustaw Rzeczypospolitej Polskiej: poz. 77. Available online: http://isap.sejm.gov.pl/isap.nsf/download.xsp/WDU20190000077/O/D20190077.pdf. [Last accessed at: June 1, 2021].
  6. Kaczmarek K, Kempa M, Grabowski M, et al. Multicentre early experience with totally subcutaneous cardioverter-defibrillators in Poland. Arch Med Sci. 2020; 16(4): 764–771.
  7. Kempa M, Przybylski A, Budrejko S, et al. Multicenter Registry of Subcutaneous Cardioverter-Defibrillator Implantations — preliminary report. Kardiol Pol. 2021 [Epub ahead of print].
  8. Jędrzejczyk-Patej E, Boveda S, Kalarus Z, et al. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey. Europace. 2018; 20(5): 887–892.
  9. Droghetti A, Basso Ricci E, Scimia P, et al. Ultrasound-guided serratus anterior plane block combined with the two-incision technique for subcutaneous ICD implantation. Pacing Clin Electrophysiol. 2018; 41(5): 517–523.
  10. van der Stuijt W, Baalman SWE, Brouwer TF, et al. Long-term follow-up of the two-incision implantation technique for the subcutaneous implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2020; 43(12): 1476–1480.
  11. Quast AFBE, Baalman SWE, Brouwer TF, et al. A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score. Heart Rhythm. 2019; 16(3): 403–410.
  12. Kempa M, Sterliński M, Mitkowski P, et al. Safety issues in selected patients implanted with Boston Scientific EMBLEM subcutaneous cardioverter defibrillator systems. Kardiol Pol. 2021; 79(2): 223–224.
  13. Boersma LV, El-Chami MF, Bongiorni MG, et al. Understanding outcomes with the EMBLEM S-ICD in primary prevention patients with low EF study (UNTOUCHED): clinical characteristics and perioperative results. Heart Rhythm. 2019; 16(11): 1636–1644.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl